Differences in Treatment, Outcomes, and Quality of Life Among Patients With Heart Failure in Canada and the United States

JACC: Heart Failure

Volumn 1, Issue 6, 2013, Pages 523-530

  Kaul, Padma ^a   Reed, Shelby D ^b   Hernandez, Adrian F ^b   Howlett, Jonathan G ^c   Ezekowitz, Justin A ^a   Li, Yanhong ^b   Zheng, Yinggan ^a   Rouleau, Jean L ^d   Starling, Randall C ^e   O'Connor, Christopher M ^b   Califf, Robert M ^f   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

^e LERNER RESEARCH INSTITUTE   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hospital stay; Mortality; Outcomes; Quality of life

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ADULT; AGE; AGED; ANXIETY; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BREATHING RATE; CANADA; CARDIAC IMAGING; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL (TOPIC); COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; EPIDEMIOLOGY; FEMALE; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAIN; PHYSICAL MOBILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; SELF CARE; TIME; TRANSTHORACIC ECHOCARDIOGRAPHY; UNITED STATES; CLINICAL TRIAL; COMPARATIVE STUDY; HEALTH CARE PLANNING; HEALTH STATUS; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UTILIZATION;

AGED; CANADA; FEMALE; HEALTH RESOURCES; HEALTH STATUS; HEART FAILURE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES;

EID: 84888992636     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.07.004     Document Type: Article

References (16)

1. Ko D.T., Krumholz H.M., Wang Y., et al. Regional differences in process of care and outcomes for older acute myocardial infarction patients inthe United States and Ontario, Canada. Circulation 2007, 115:196-203.
2. Kaul P., Armstrong P.W., Chang W.-C., et al. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. Circulation 2004, 110:1754-1760.
3. Fu Y., Chang W.C., Mark D., et al. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up ofpatients without ST-segment elevation. Circulation 2000, 102:1375-1381. for the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
4. Tu J.V., Pashos C.L., Naylor C.D., et al. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. NEngl J Med 1997, 336:1500-1505.
5. Mark D.B., Naylor C.D., Hlatky M.A., et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. NEngl J Med 1994, 331:1130-1135.
6. Rouleau J.L., Moyé L.A., Pfeffer M.A., et al. Acomparison of management patterns after acute myocardial infarction in Canada and the United States. NEngl J Med 1993, 328:779-784. for the SAVE Investigators.
7. Ko D.T., Tu J.V., Masoudi F.A., et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med 2005, 165:2486-2492.
8. O'Connor C.M., Starling R.C., Hernandez A.F., et al. Effect of nesiritide in patients with acute decompensated heart failure. NEngl J Med 2011, 365:32-43.
9. Hernandez A.F., O'connor C.M., Starling R.C., et al. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure trial (ASCEND-HF). Am Heart J 2009, 157:271-277.
10. Dyer M.T.D., Goldsmith K.A., Sharples L.S., Buxton M.J. Areview of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010, 8:13.
11. Quan H., Sundararajan V., Halfon P., et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005, 43:1130-1139.
12. Quan H., Li B., Saunders L.D., et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res 2008, 43:1424-1441.
13. Eapen Z.J., Reed S.D., Li Y., et al. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates? Findings from ASCEND-HF. Circ Heart Fail 2013, 6:727-732.
14. Kaul P., McAlister F.A., Ezekowitz J.A., et al. Resource use in the last 6 months of life among patients with heart failure in Canada. Arch Intern Med 2011, 171:211-217.
15. Unroe K.T., Greiner M.A., Hernandez A.F., et al. Resource use in the last 6 months of life among Medicare beneficiaries with heart failure 2000-2007. Arch Intern Med 2011, 171:196-203.
16. Dai S., Walsh P., Wielgosz A., Gurevich Y., Bancej C., Morrison H. Comorbidities and mortality associated with hospitalized heart failure in Canada. Can J Cardiol 2012, 28:74-79.